China Resources Pharmaceutical
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
China Resources Pharmaceutical announces 10% stake purchase in Yongtai Bioscience
China Resources Pharmaceutical said its wholly owned subsidiary purchased 51,458,400 ordinary shares in Yongtai Bioscience, representing 10% of Yongtai's issued share capital, for approximately HK$799.7 million. The report states that China Resources Pharmaceutical would become Yongtai's major shareholder after completion.